C-CAMP Gets a ₹500 Crore RDI Fund Commitment: What It Means for Biotech Founders
Bengaluru’s C-CAMP has a ₹500 crore commitment under the Centre’s RDI Fund and plans a consortium of more than ₹1,000 crore for deeptech life-sciences startups. How to apply has not been announced yet.
The Centre for Cellular and Molecular Platforms (C-CAMP) in Bengaluru has been picked as one of five Focused Research Organisations (FROs) under the Centre’s Research, Development and Innovation (RDI) Fund, with a funding commitment of ₹500 crore to back deeptech innovation. The news was reported on 16 October 2026.
For biotech and life-science founders, this matters more than most fund announcements. C-CAMP is the only dedicated biotechnology organisation among the fund managers named under the RDI Fund, so this is the money in that programme most clearly aimed at your sector.
What was announced
- C-CAMP will receive a funding commitment of ₹500 crore under the RDI Fund.
- It plans to work with private partners and investors to build a consortium with more than ₹1,000 crore in total, including the ₹500 crore.
- That money is meant for deeptech life-sciences startups building technology with potential for impact in India and globally.
- C-CAMP says it will look for high-risk, potentially transformative work in healthcare, agriculture, food security and environmental sustainability.
C-CAMP describes itself as a bioscience research and innovation hub and life-sciences incubator under the Department of Biotechnology, Ministry of Science and Technology, according to The Hindu.
Where C-CAMP sits in the RDI Fund
The government named 19 Second Level Fund Managers (SLFMs) under the initiative: five FROs and 14 investment funds, with an allocation of ₹7,131 crore. The Times of India describes the 14 as venture capital firms; The Hindu calls them Alternative Investment Funds.
The other four FROs are:
- Indian Institute of Science (IISc)
- IIT Bombay
- IIT Madras
- BITS Pilani
So the fund does not hand money to startups only from the centre. It routes a large share through these managers, who then pick and back companies. If you are a biotech founder, C-CAMP is the manager whose whole focus is your field.
A quick refresher on the RDI Fund
- Prime Minister Narendra Modi announced the RDI Fund on 3 November 2025.
- It is a ₹1 lakh crore initiative spread over six years.
- Its aim is to bring more private-sector money into research and innovation, and to fill the gap in patient capital for high-risk, high-potential sectors such as deeptech.
- The Union Cabinet approved it on 1 July 2025.
- It has already supported 22 startups through direct project funding. Two of them, Eyestem Research and Peptris Technologies, are in C-CAMP’s portfolio.
The TRL 4 bar: the eligibility point to check first
The one eligibility condition the reports mention is technology maturity. The RDI Fund backs technologies at Technology Readiness Level (TRL) 4 and above. In plain terms, your technology should have moved beyond the early lab stage and be closer to practical use and the market.
If your work is still at the idea or early-experiment stage, this money is probably not for you yet. If you have validated your technology beyond early lab work and are heading towards real-world use, you are in the range this fund is talking about.
What C-CAMP’s leadership said
C-CAMP Director-CEO Dr Taslimarif Saiyed said the selection would help bring more Indian deeptech startups closer to real-world impact. In C-CAMP’s statement, he said lack of funding is currently a bottleneck for India’s biotech innovators trying to compete globally, and that C-CAMP would work to remove it.
He said C-CAMP would target both patient capital to nurture ideas and disciplined investment to shape the commercial path of deep-science ventures. He also said C-CAMP wants to bring more private money into the deeptech ecosystem through its network.
What has not been announced yet
The reports do not say:
- How or when startups can apply for funding from C-CAMP’s RDI allocation.
- The size of individual investments, or whether money will come as equity, loans or another form.
- Any eligibility rules beyond the TRL 4 condition.
- Which private partners will join the consortium.
Until C-CAMP or the government publishes these details, treat any “apply now” claim you see for this fund with caution.
What this means for you
Who it helps: founders building deeptech in health, agriculture, food or environment, whose technology is at TRL 4 or beyond. It is not a general MSME scheme, and it is not grant money for early ideas.
What to do now:
- Work out your TRL honestly. Write one paragraph on what you have proven, where (lab, pilot, field) and what is left. A fund manager working to a TRL 4 bar will ask this first.
- Get your data room ready. Keep your validation data, IP status and a clear plan from prototype to market in one place, so you can move quickly when the application route opens.
- Follow C-CAMP’s official channels for the call. Don’t rely on third-party forms.
- Know the other doors. If your startup is deeptech but not biotech, remember that IISc, IIT Bombay, IIT Madras and BITS Pilani are also FROs under the same RDI Fund.
Sources: The Times of India (16 October 2026) and The Hindu (16 October 2026), including C-CAMP’s statement.
Cover photo: National Cancer Institute on Unsplash
